APA (7th ed.) Citation

LC, T., & K, M. (2023). Base Editing and Prime Editing: Potential Therapeutic Options for Rare and Common Diseases. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 37(4), 453. https://doi.org/10.1007/s40259-023-00610-9

Chicago Style (17th ed.) Citation

LC, Testa, and Musunuru K. "Base Editing and Prime Editing: Potential Therapeutic Options for Rare and Common Diseases." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 37, no. 4 (2023): 453. https://doi.org/10.1007/s40259-023-00610-9.

MLA (9th ed.) Citation

LC, Testa, and Musunuru K. "Base Editing and Prime Editing: Potential Therapeutic Options for Rare and Common Diseases." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 37, no. 4, 2023, p. 453, https://doi.org/10.1007/s40259-023-00610-9.